- $1.62bn
- $1.67bn
- $3.64bn
- 83
- 63
- 36
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,071 | 2,247 | 2,498 | 3,009 | 3,644 |
Cost of Revenue | |||||
Gross Profit | 214 | 276 | 325 | 344 | 364 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,014 | 2,161 | 2,380 | 2,894 | 3,515 |
Operating Profit | 57.2 | 86.5 | 119 | 115 | 129 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 50.4 | 81.4 | 116 | 114 | 125 |
Provision for Income Taxes | |||||
Net Income After Taxes | 36.2 | 58.8 | 85 | 83.4 | 91 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 37.7 | 58.8 | 85 | 83.4 | 91 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 37.7 | 58.8 | 85 | 83.4 | 91 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.1 | 3.36 | 4.82 | 4.81 | 5.22 |